Search - tctmd.com

Displaying 1 - 20 of 74

Sort: Relevancy | Date

News Daily News

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

L.A. McKeown

January 06, 2025

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

L.A. McKeown

May 30, 2024

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Daily News

BP Reduction With Renal Denervation Still Evident a Decade On

Michael O'Riordan

January 31, 2023

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

News Industry News

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

April 26, 2018

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

Advertisement

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

Kidney Events High in Older Patients After HF Hospitalization

November 2023 News Roundup

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

BP Reduction With Renal Denervation Still Evident a Decade On

September 2022 News Roundup

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

January 2022 News Roundup

December 2021 News Roundup

November 2021 News Roundup

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Renal Function Gains Seen in CKD Patients After TAVR

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content